Clinical Trial Update: Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This update reports results from a Phase 1 study evaluating the combination of docetaxel and imatinib mesylate in patients with locally advanced or metastatic b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gleevec (Imatinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED